Business Models of Non-Practicing Entities

 

In the discussion of organizations that provide technology or patent rights to others, Non-Practicing Entities or as some of them are called "Patent trolls" are always debated. My objective with this post is to introduce the concepts and explain the frequently disputed business model.

A few words about patents

A patent is an exclusive right to prevent others from making, using, selling or distributing an invention that is considered new, non-obvious and useful or industrially applicable. A patent does not give the proprietor of the patent the right to use the patented invention, should it fall within the scope of an earlier patent. Patents per se has nothing to do with the business model used by the patent holder or the pricing of products; Skype, Google, and other firms known for providing free services to their users, is still developing and filing patents to claim their rights to inventions, primarily to keep competitors away.

A patent is a limited right (often 20 years from the filing date) that the government offers to inventors in exchange for their agreement to share the details of their invention with the public. The patent system incentivizes organizations to invest in research and development, and to disclose instead of keeping inventions secret in exchange for exclusivity. Being able to keep competitors away for a limited time, gives the inventor the chance to recover their up-front investment in making the invention. For a new pharmaceutical drug this investment can be billions of dollars. In contrast to some granted patents covering software or business methods, the investment can in some cases be close to zero excluding the costs of patent filing. Like any other property right, a patent may be sold, licensed, mortgaged, assigned or transferred, given away or abandoned.

Monetizing innovations

A university researcher or single inventor can chose to start a company to manufacture and sell products based on its research outcome, or chose to use the exclusive right status of a patent to become a licensor. This allows the inventor to accumulate capital from licensing the invention so the inventor's time and energy can be spent on pure innovation, allowing others to concentrate on manufacturability and marketing of downstream products. This can be seen as a straight forward application of Adam Smith's division of labor that having a group of people focus exclusively on inventing new things.

There are numbers of research-based companies that develop new technology or pharmaceutical drugs just to license it to other firms to commercialize. The object for transaction can be just the right to exclude someone, or it can be drawings, data, relating non-patented inventions, knowledge in different forms, knowhow etc.

This ability to assign ownership or rights increases the liquidity of patents as property. Third parties can license or acquire patents and the same rights to prevent others from exploiting the inventions, as if they had originally made the inventions themselves. Small companies or individual inventors that don't have the funds to claim their rights against multinational companies can sell their patents to companies willing to enforce them against infringers.

Licensing of patents is nothing new. In 1894, American Bell Telephone Company's R&D department licensed 73 patents from outside inventors, developing only 12 inventions from its own employees.

Cross-licensing of patent rights

It is common for companies engaged in complex technical fields to enter into license agreements associated with the production of a single product. Scott McGregor, President & CEO of Broadcom, has said that "a cell phone these days can have hundreds of devices that are part of it; each one of those can have hundreds of aspects to it. You could literally have a million or more patents that would apply to a single handset". It is therefore common that even competitors license patents to each other under cross-licensing agreements in order to share the benefits of using each other's patented inventions and reduce the risk of being sued by the other party.

When one company sues another (Nokia vs Apple) the other company often countersues the first one (Apple vs Nokia) and the litigation process often results in that the parties come to an agreement, cross license patents, and pay licensing fees to the company with a stronger case. Counter-assertion is an important stabilizing force in many patent disputes.

Non-Practicing Entities - a question of value proposition

A non-practicing entity (NPE) is a patent owner who does not manufacture or use patented inventions but rather than abandoning the rights to exclude, an NPE seeks to license the rights to others. The value proposition is thus not a product or service, but the rights to an invention with or without supporting knowledge and know-how. A single inventor, a university, a research institute, an SME, a multinational company or an investment fund, can all be non-practicing entities, depending on their choice of business model.

The term patent troll is sometimes used for NPEs that enforce its patents against one or more alleged infringers in an aggressive or opportunistic manner. The general idea of these firms is to develop a large patent portfolio and to license these patents to companies that infringe on them or potentially filing lawsuits against these companies if they refuse to take a license. In some cases the NPE analyze popular products on the market to find remote patents that could be infringed, and approach the patent holder to acquire or get a license to sue.

In some cases these firms have as their business model to purchase patents, often cheaply from technology companies forced by bankruptcy to auction its patents, with the sole purpose to sue and enforce it against companies that manufacture or market products, potentially infringing any of the patents. Some of those accused of being patent trolls argue that they are the modern incarnation of Robin Hood helping smaller companies and inventors against large companies who have stolen their ideas.

Legal extortion or value proposition?

To seek to derive income from the enforcement of patent rights is perfectly legal but it sometimes has troubling implications for the makers and sellers of products and services. As the entity is not selling products or services, almost by definition it does not infringe on the patent rights contained by others, thus they are essentially invulnerable to counter-assertion.

This gives NPEs a position to negotiate licensing fees that could be argued to be out of alignment with their contribution to the alleged infringer's product or service. As a result, a patent held by an NPE is often considered more threatening to industry participants than the same patent held by a competitor. As a result of that, there are operating companies that sell their patents to NPEs to assert the patents without the operating company being involved.

The more dubious NPEs can see even a weak patent as a lottery ticket hoping the alleged infringer chose to pay up without completing a lawsuit. If the defendant chooses to litigate then both sides must absorb heavy litigation costs no matter who wins. As even a successful litigant must pay the costs of defending its case, and that the cost can run into the millions, operating companies may chose to pay up even though they probably would win if they take the case all the way through trial, to avoid the time, expense, and uncertainty. This is something that the more dubious NPEs take into consideration when they approach operating companies.

Revenue model of Non-Practicing Entities

NPEs generate revenues through licensing agreements or damages awarded by a court. Licensing agreements can include up-front license fees, milestone payments contingent upon achieving certain goals, and royalty revenue from the commercialization of the licensed technology. Damages are awarded on the basis of how much value the defendant is obtaining as a result of its infringing activity.

Activities performed by Non-Practicing Entities

All NPEs have to manage their patent portfolios, and identifying existing or potential application areas. Independent of being a single inventor, a university or a patent holding company, activities also involve finding potential licensees, negotiating terms and conditions and collecting license fees. Most NPEs also have internal research and development and patent filing and maintenance activities. There is a continuum from organizations that are doing substantial investments in R&D to generate inventions and patents, and organizations focusing on acquiring and aggregating others' patents.

The good guys and the bad guys

The business model of Non-Practicing Entities is widely debated and there are firms with dubious motifs. Companies that do not manufacture or intend to manufacture anything are often seen as profiting from others in a negative way (at least in the media). At the same time companies outsource or move production to low cost countries, leaving the western world to be “the innovators” where the output is innovation and intellectual property.

Good guys can be found in both ends of the scale, providing valuable inventions, knowledge, data, instructions or knowhow to manufacturing companies, or just aggregating and providing the rights reducing the time and cost for manufacturing companies to find all relevant patents covering a technology area. Without the existence of entities willing to buy patents as a last resort there’s no credible threat a single inventor can make towards a large company. A rational defendant will simply carry on knowing the patent can’t be successfully enforced, and inventors at the margins may not undertake their research in the first place.

https://tinyurl.com/4nbwf5e2

Drugs with no patents and no competition – here’s our list of new ‘price-gouging’ targets

Drug price increases have emerged as a core strategy for generic pharmaceutical companies in the recent past. In September last year, Martin Shkreli’s decision to increase the price of Daraprim (Pyrimethamine) from US $ 13.50 per tablet to US $ 750 overnight, received an angry tweet from Hillary Clinton. “Price gouging like this in the specialty drug market is outrageous,” she had tweeted. 

Shkreli of Turing Pharmaceuticals wasn’t the only one hiking prices of drugs. ‘Price gouging’ has become a hot topic, and synonymous with the activities of many major pharmaceutical companies. 

Price increase due to ownership, not improved science

Valeant Pharmaceuticals, a stock market darling until recently, developed a strategy of buying up companies and dramatically increasing the price of the acquired drugs.

In February 2015, Valeant purchased two life-saving heart drugs – Isuprel and Nitropress. And the same day, Valeant increased the prices of these drugs by 525 percent and 212 percent respectively. The increase was not an outcome of improved science but simply a change of ownership.

Similarly, on January 1, 2016, Pfizer raised prices of more than 100 of its drugs. According to global information services company Wolters Kluwer the price increase was as much as 20 percent in the case of some medicines.

Another recent study on US drug prices uncovered that “prices for four of the nation's top 10 drugs increased more than 100 percent since 2011, Reuters found. Six others went up more than 50 percent.”

“It’s not funny, Mr. Shkreli. People are dying”

Scrutiny on drug price increases and its accounting practices has made Valeant Pharmaceuticals, which not so long ago was the biggest company on the Toronto Stock Exchange (TSX), lose 90 per cent of its market value in less than a year. 

“Pharma Bro” Shkreli was arrested in December for allegedly bilking tens of millions of dollars from his former biotech venture, Retrophin.

And while he smirked his way through the Senate hearing on drug price increases, he was rebuked by Representative Elijah Cummings. “It’s not funny, Mr. Shkreli. People are dying, and they are getting sicker and sicker,” he told Shkreli, as the latter grinned during the Congressman’s opening statement. 

The appearance by Shkreli was the highlight of this congressional hearing, which explored the complicated reality of drug pricing in the US.

Bernie Sanders, a US presidential candidate, has long been protesting “skyrocketing drug prices” and has also proposed a new bill last year – The Prescription Drug Affordability Act of 2015.

FDA’s accelerated review plan

In this backdrop, the US Food and Drug Administration (FDA) announced a small regulatory change – it will prioritize review of new applications for generic drugs “that would compete with treatments made by only one company.”

The policy mentions that “potential first generic products for which there are no blocking patents or exclusivities on the reference listed drug may receive expedited review”. 

In an email to Bloomberg, the FDA estimates the change in prioritization could expedite review of as many as 125 generic drug applications. 

The next ‘price-gouging’ targets

PharmaCompass has found over 300 different dosage forms of drugs which currently have no patents and no competition.

Our compilation covers a broad range of products from Pfizer's Premarin, isolated from pregnant mares’ urine, which brings in over US $ 1 billion in sales to Emcure’s BICNU (carmustine or BICNU is an anti-cancer, chemotherapy drug).

While Emcure was banned from exporting products to the United States, due to compliance problems found in their manufacturing operations, BICNU was exempted since there was no other alternative available in the market.

While an estimated 13 million people in the United States have latent tuberculosis infection (LTBI), Sanofi’s Priftin (rifapentine), launched last year in a new packaging, still has no generic competition.

Our view

Our list provides tremendous opportunities for generic companies in the short-term. In many cases, to capitalize on the opportunities, generic drug companies will need to partner with API manufacturers as the lack of sustained, quality API supply is a major reason that there are no competitors on the market.

However, it is important for generic companies to remember that the FDA’s continued focus on accelerating review of these drugs will require companies to rely on strategies less opportunistic than price-gouging, to drive their future business growth.

Active Ingredient	Dosage Form	Trade Name	Dosage Strength	NDA (N) /ANDA (A)	Application Number	Approval Date	Application Holder
ACETIC ACID, GLACIAL; ALUMINUM ACETATE	SOLUTION/DROPS;OTIC	ACETIC ACID 2% IN AQUEOUS ALUMINUM ACETATE	2%;0.79%	A	40063	2/25/1994	BAUSCH AND LOMB PHARMACEUTICALS INC
CORTICORELIN OVINE TRIFLUTATE	INJECTABLE;INJECTION	ACTHREL	EQ 0.1MG BASE/VIAL	N	20162	5/23/1996	FERRING PHARMACEUTICALS INC
PEGADEMASE BOVINE	INJECTABLE;INJECTION	ADAGEN	250 UNITS/ML	N	19818	3/21/1990	SIGMA TAU PHARMACEUTICALS INC
ADAPALENE	SOLUTION;TOPICAL	ADAPALENE	0.10%	A	204593	1/5/2016	CALL INC DBA ROCHESTER PHARMACEUTICALS
ERYTHROMYCIN	OINTMENT;TOPICAL	AKNE-MYCIN	2%	N	50584	1/10/1985	DOW PHARMACEUTICAL SCIENCES
ALBENDAZOLE	TABLET;ORAL	ALBENZA	200MG	N	20666	6/11/1996	AMEDRA PHARMACEUTICALS LLC
LODOXAMIDE TROMETHAMINE	SOLUTION/DROPS;OPHTHALMIC	ALOMIDE	EQ 0.1% BASE	N	20191	9/23/1993	ALCON LABORATORIES INC
ALPRAZOLAM	CONCENTRATE;ORAL	ALPRAZOLAM	1MG/ML	A	74312	10/31/1993	ROXANE LABORATORIES INC
AMANTADINE HYDROCHLORIDE	TABLET;ORAL	AMANTADINE HYDROCHLORIDE	100MG	A	76186	12/16/2002	USL PHARMA INC
AMCINONIDE	LOTION;TOPICAL	AMCINONIDE	0.10%	A	76329	11/6/2002	FOUGERA PHARMACEUTICALS INC
AMMONIUM CHLORIDE	INJECTABLE;INJECTION	AMMONIUM CHLORIDE IN PLASTIC CONTAINER	5MEQ/ML	A	88366	6/13/1984	HOSPIRA INC
AMPHOTERICIN B	INJECTABLE;INJECTION	AMPHOTERICIN B	50MG/VIAL	A	63206	4/29/1992	X GEN PHARMACEUTICALS INC
INAMRINONE LACTATE	INJECTABLE;INJECTION	AMRINONE LACTATE	EQ 5MG BASE/ML	A	75513	5/9/2000	EUROHEALTH INTERNATIONAL SARL
OXYMETHOLONE	TABLET;ORAL	ANADROL-50	50MG	N	16848	1/1/1982	MEDA PHARMACEUTICALS INC
VITAMIN A PALMITATE	INJECTABLE;INJECTION	AQUASOL A	EQ 50,000 UNITS BASE/ML	N	6823	1/1/1982	HOSPIRA INC
DOXYCYCLINE HYCLATE	SYSTEM, EXTENDED RELEASE;PERIODONTAL	ATRIDOX	50MG	N	50751	9/3/1998	TOLMAR INC
ATROPINE SULFATE	SOLUTION/DROPS;OPHTHALMIC	ATROPINE SULFATE	1%	N	206289	7/18/2014	AKORN INC
AZATHIOPRINE SODIUM	INJECTABLE;INJECTION	AZATHIOPRINE SODIUM	EQ 100MG BASE/VIAL	A	74419	3/31/1995	EUROHEALTH INTERNATIONAL SARL
AZELAIC ACID	CREAM;TOPICAL	AZELEX	20%	N	20428	9/13/1995	ALLERGAN INC
BRINZOLAMIDE	SUSPENSION/DROPS;OPHTHALMIC	AZOPT	1%	N	20816	4/1/1998	ALCON PHARMACEUTICALS LTD
SULFASALAZINE	SUSPENSION;ORAL	AZULFIDINE	250MG/5ML	A	86983	1/1/1982	PHARMACIA AND UPJOHN CO
BACITRACIN	OINTMENT;OPHTHALMIC	BACITRACIN	500 UNITS/GM	A	61212	1/1/1982	PERRIGO CO TENNESSEE INC
MUPIROCIN CALCIUM	OINTMENT;NASAL	BACTROBAN	EQ 2% BASE	N	50703	9/18/1995	GLAXOSMITHKLINE
DIMERCAPROL	INJECTABLE;INJECTION	BAL	10%	N	5939	1/1/1982	AKORN INC
BECLOMETHASONE DIPROPIONATE MONOHYDRATE	SPRAY, METERED;NASAL	BECONASE AQ	EQ 0.042MG DIPROP/SPRAY	N	19389	7/27/1987	GLAXOSMITHKLINE
POVIDONE-IODINE	SOLUTION/DROPS;OPHTHALMIC	BETADINE	5%	N	18634	12/17/1986	ALCON PHARMACEUTICALS LTD
BETAXOLOL HYDROCHLORIDE	SUSPENSION/DROPS;OPHTHALMIC	BETOPTIC S	EQ 0.25% BASE	N	19845	12/29/1989	ALCON LABORATORIES INC
CARMUSTINE	INJECTABLE;INJECTION	BICNU	100MG/VIAL	N	17422	1/1/1982	EMCURE PHARMACEUTICALS LTD
PRAZIQUANTEL	TABLET;ORAL	BILTRICIDE	600MG	N	18714	12/29/1982	BAYER HEALTHCARE PHARMACEUTICALS INC
PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM	OINTMENT;OPHTHALMIC	BLEPHAMIDE S.O.P.	0.2%;10%	A	87748	12/3/1986	ALLERGAN PHARMACEUTICAL
ACETAMINOPHEN; BUTALBITAL; CAFFEINE	SOLUTION;ORAL	BUTALBITAL, ACETAMINOPHEN AND CAFFEINE	325MG/15ML;50MG/15ML;40MG/15ML	A	40387	1/31/2003	MIKART INC
CALCIPOTRIENE	OINTMENT;TOPICAL	CALCIPOTRIENE	0.01%	A	90633	3/24/2010	GLENMARK GENERICS INC USA
CALCITRIOL	INJECTABLE;INJECTION	CALCITRIOL	0.001MG/ML	A	78066	1/29/2008	AKORN INC
CALCIUM CHLORIDE	INJECTABLE;INJECTION	CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER	100MG/ML	N	21117	1/28/2000	HOSPIRA INC
EDETATE CALCIUM DISODIUM	INJECTABLE;INJECTION	CALCIUM DISODIUM VERSENATE	200MG/ML	N	8922	1/1/1982	MEDICIS PHARMACEUTICAL CORP
CAPREOMYCIN SULFATE	INJECTABLE;INJECTION	CAPASTAT SULFATE	EQ 1GM BASE/VIAL	N	50095	1/1/1982	AKORN INC
FLUOCINOLONE ACETONIDE	SHAMPOO;TOPICAL	CAPEX	0.01%	N	20001	8/27/1990	GALDERMA LABORATORIES LP
ACETAMINOPHEN; CODEINE PHOSPHATE	SUSPENSION;ORAL	CAPITAL AND CODEINE	120MG/5ML;12MG/5ML	A	86024	1/1/1982	VALEANT PHARMACEUTICALS NORTH AMERICA LLC
SUCRALFATE	SUSPENSION;ORAL	CARAFATE	1GM/10ML	N	19183	12/16/1993	FOREST LABORATORIES INC
RUBIDIUM CHLORIDE RB-82	INJECTABLE;INJECTION	CARDIOGEN-82	N/A	N	19414	12/29/1989	BRACCO DIAGNOSTICS INC
ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE	TABLET;ORAL	CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE	325MG;200MG;16MG	A	40118	4/16/1996	SANDOZ INC
CEFAZOLIN SODIUM	SOLUTION;INTRAVENOUS	CEFAZOLIN IN PLASTIC CONTAINER	EQ 2GM BASE/100ML (EQ 20MG BASE/ML)	N	207131	8/7/2015	BAXTER HEALTHCARE CORP
CEFOXITIN SODIUM	POWDER;IV (INFUSION)	CEFOXITIN IN PLASTIC CONTAINER	EQ 100GM BASE	A	200938	11/16/2015	SAMSON MEDICAL TECHNOLOGIES LLC
MYCOPHENOLATE MOFETIL HYDROCHLORIDE	INJECTABLE;INJECTION	CELLCEPT	500MG/VIAL	N	50758	8/12/1998	ROCHE PALO ALTO LLC
TECHNETIUM TC-99M EXAMETAZIME KIT	INJECTABLE;INJECTION	CERETEC	N/A	N	19829	12/30/1988	GE HEALTHCARE
DINOPROSTONE	INSERT, EXTENDED RELEASE;VAGINAL	CERVIDIL	10MG	N	20411	3/30/1995	FERRING PHARMACEUTICALS INC
NABILONE	CAPSULE;ORAL	CESAMET	1MG	N	18677	12/26/1985	MEDA PHARMACEUTICALS INC
CIPROFLOXACIN HYDROCHLORIDE	SOLUTION/DROPS;OTIC	CETRAXAL	EQ 0.2% BASE	N	21918	5/1/2009	WRASER PHARMACEUTICALS LLC
CHENODIOL	TABLET;ORAL	CHENODIOL	250MG	A	91019	10/22/2009	NEXGEN PHARMA INC
CHLORAMPHENICOL SODIUM SUCCINATE	INJECTABLE;INJECTION	CHLORAMPHENICOL SODIUM SUCCINATE	EQ 1GM BASE/VIAL	A	62365	8/25/1982	FRESENIUS KABI USA LLC
CHLORPROMAZINE HYDROCHLORIDE	INJECTABLE;INJECTION	CHLORPROMAZINE HYDROCHLORIDE	25MG/ML	A	83329	1/1/1982	EUROHEALTH INTERNATIONAL SARL
CHROMIC CHLORIDE	INJECTABLE;INJECTION	CHROMIC CHLORIDE IN PLASTIC CONTAINER	EQ 0.004MG CHROMIUM/ML	N	18961	6/26/1986	HOSPIRA INC
CIPROFLOXACIN HYDROCHLORIDE	OINTMENT;OPHTHALMIC	CILOXAN	EQ 0.3% BASE	N	20369	3/30/1998	ALCON PHARMACEUTICALS LTD
CIMETIDINE HYDROCHLORIDE	INJECTABLE;INJECTION	CIMETIDINE HYDROCHLORIDE	EQ 300MG BASE/2ML	A	74428	4/25/1996	DAVA PHARMACEUTICALS INC
CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE	SUSPENSION/DROPS;OTIC	CIPRO HC	EQ 0.2% BASE;1%	N	20805	2/10/1998	ALCON PHARMACEUTICALS LTD
ESTRADIOL; LEVONORGESTREL	FILM, EXTENDED RELEASE;TRANSDERMAL	CLIMARA PRO	0.045MG/24HR;0.015MG/24HR	N	21258	11/21/2003	BAYER HEALTHCARE PHARMACEUTICALS INC
CLOCORTOLONE PIVALATE	CREAM;TOPICAL	CLODERM	0.10%	N	17765	1/1/1982	PROMIUS PHARMA LLC
COLISTIN SULFATE; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; THONZONIUM BROMIDE	SUSPENSION/DROPS;OTIC	COLY-MYCIN S	EQ 3MG BASE/ML; 10MG/ML;EQ 3.3MG BASE/ML; 0.5MG/ML	N	50356	1/1/1982	ENDO PHARMACEUTICALS INC
PODOFILOX	GEL;TOPICAL	CONDYLOX	0.50%	N	20529	3/13/1997	ACTAVIS LABORATORIES UT INC
FLURANDRENOLIDE	LOTION;TOPICAL	CORDRAN	0.05%	N	13790	1/1/1982	AQUA PHARMACEUTICALS
FLURANDRENOLIDE	OINTMENT;TOPICAL	CORDRAN	0.05%	N	12806	1/1/1982	AQUA PHARMACEUTICALS
FLURANDRENOLIDE	TAPE;TOPICAL	CORDRAN	0.004MG/SQ CM	N	16455	1/1/1982	ACTAVIS LABORATORIES UT INC
HYDROCORTISONE ACETATE	AEROSOL, METERED;RECTAL	CORTIFOAM	10%	N	17351	2/10/1982	MEDA PHARMACEUTICALS INC
HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	CREAM;TOPICAL	CORTISPORIN	0.5%;EQ 3.5MG BASE/GM; 10,000 UNITS/GM	N	50218	8/9/1985	MONARCH PHARMACEUTICALS INC
ETHINYL ESTRADIOL; NORGESTREL	TABLET;ORAL-21	CRYSELLE	0.03MG;0.3MG	A	75840	11/30/2001	DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC
CUPRIC CHLORIDE	INJECTABLE;INJECTION	CUPRIC CHLORIDE IN PLASTIC CONTAINER	EQ 0.4MG COPPER/ML	N	18960	6/26/1986	HOSPIRA INC
PENICILLAMINE	CAPSULE;ORAL	CUPRIMINE	250MG	N	19853	1/1/1982	ATON PHARMA INC
PORACTANT ALFA	SUSPENSION;INTRATRACHEAL	CUROSURF	80MG/ML	N	20744	11/18/1999	CHIESI USA INC
CYCLOPENTOLATE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	SOLUTION/DROPS;OPHTHALMIC	CYCLOMYDRIL	0.2%;1%	A	84300	1/1/1982	ALCON LABORATORIES INC
BETAINE HYDROCHLORIDE	FOR SOLUTION;ORAL	CYSTADANE	1GM/SCOOPFUL	N	20576	10/25/1996	RARE DISEASE THERAPEUTICS INC
PYRIMETHAMINE	TABLET;ORAL	DARAPRIM	25MG	N	8578	1/1/1982	TURING PHARMACEUTICALS AG
DECITABINE	POWDER;INTRAVENOUS	DECITABINE	50MG/VIAL	N	205582	1/28/2014	SUN PHARMA GLOBAL FZE
METYROSINE	CAPSULE;ORAL	DEMSER	250MG	N	17871	1/1/1982	ATON PHARMA DIV VALEANT PHARMACEUTICALS NORTH AMERICA LLC
PENICILLAMINE	TABLET;ORAL	DEPEN	250MG	N	19854	1/1/1982	MEDA PHARMACEUTICALS INC
CYTARABINE	INJECTABLE, LIPOSOMAL;INJECTION	DEPOCYT	10MG/ML	N	21041	4/1/1999	PACIRA PHARMACEUTICALS INC
DEXAMETHASONE	SOLUTION;ORAL	DEXAMETHASONE	0.5MG/5ML	A	88248	9/1/1983	ROXANE LABORATORIES INC
DEXAMETHASONE	CONCENTRATE;ORAL	DEXAMETHASONE INTENSOL	1MG/ML	A	88252	9/1/1983	ROXANE LABORATORIES INC
DEXCHLORPHENIRAMINE MALEATE	SYRUP;ORAL	DEXCHLORPHENIRAMINE MALEATE	2MG/5ML	A	88251	3/23/1984	WOCKHARDT EU OPERATIONS (SWISS) AG
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM LACTATE	INJECTABLE;INJECTION	DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER	5GM/100ML; 31MG/100ML; 141MG/100ML; 20MG/100ML; 12MG/100ML; 260MG/100ML	N	17484	1/1/1982	BAXTER HEALTHCARE CORP
DIAZEPAM	SOLUTION;ORAL	DIAZEPAM	5MG/5ML	A	70928	4/3/1987	ROXANE LABORATORIES INC
DICYCLOMINE HYDROCHLORIDE	SYRUP;ORAL	DICYCLOMINE HYDROCHLORIDE	10MG/5ML	A	40169	3/24/2005	MIKART INC
DIGOXIN	ELIXIR;ORAL	DIGOXIN	0.05MG/ML	N	21648	8/26/2004	ROXANE LABORATORIES INC
ISOSORBIDE DINITRATE	CAPSULE, EXTENDED RELEASE;ORAL	DILATRATE-SR	40MG	N	19790	9/2/1988	AUXILIUM PHARMACEUTICALS LLC
DIMENHYDRINATE	INJECTABLE;INJECTION	DIMENHYDRINATE	50MG/ML	A	40519	6/23/2004	FRESENIUS KABI USA LLC
OLSALAZINE SODIUM	CAPSULE;ORAL	DIPENTUM	250MG	N	19715	7/31/1990	MEDA PHARMACEUTICALS INC
DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE;ORAL	DIPHENHYDRAMINE HYDROCHLORIDE	50MG	A	80738	1/1/1982	BARR LABORATORIES INC
DIPHENHYDRAMINE HYDROCHLORIDE	ELIXIR;ORAL	DIPHENHYDRAMINE HYDROCHLORIDE	12.5MG/5ML	A	87513	2/10/1982	PHARMACEUTICAL ASSOC INC DIV BEACH PRODUCTS
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	SOLUTION;ORAL	DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE	0.025MG/5ML;2.5MG/5ML	A	87708	5/3/1982	ROXANE LABORATORIES INC
CHLOROTHIAZIDE	SUSPENSION;ORAL	DIURIL	250MG/5ML	N	11870	1/1/1982	SALIX PHARMACEUTICALS INC
METHADONE HYDROCHLORIDE	INJECTABLE;INJECTION	DOLOPHINE HYDROCHLORIDE	10MG/ML	N	21624	1/1/1982	MYLAN INSTITUTIONAL LLC
ATROPINE; PRALIDOXIME CHLORIDE	INJECTABLE;INTRAMUSCULAR	DUODOTE	2.1MG/0.7ML;600MG/2ML	N	21983	9/28/2006	MERIDIAN MEDICAL TECHNOLOGIES INC
ASPIRIN	CAPSULE, EXTENDED RELEASE;ORAL	DURLAZA	162.5MG	N	200671	9/4/2015	NEW HAVEN PHARMACEUTICALS INC
ETHACRYNIC ACID	TABLET;ORAL	EDECRIN	25MG	N	16092	1/1/1982	ATON PHARMA INC
THEOPHYLLINE	SOLUTION, ELIXIR;ORAL	ELIXOPHYLLIN	80MG/15ML	A	85186	1/1/1982	NOSTRUM LABORATORIES INC
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	INJECTABLE;INTRATHECAL	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML; 0.3MG/ML;0.3MG/ML; 1.9MG/ML;7.3MG/ML; 0.2MG/ML	N	20577	9/27/1996	LUKARE MEDICAL LLC
PENTOSAN POLYSULFATE SODIUM	CAPSULE;ORAL	ELMIRON	100MG	N	20193	9/26/1996	JANSSEN PHARMACEUTICALS INC
EMEDASTINE DIFUMARATE	SOLUTION/DROPS;OPHTHALMIC	EMADINE	0.05%	N	20706	12/29/1997	ALCON LABORATORIES INC
ESTRAMUSTINE PHOSPHATE SODIUM	CAPSULE;ORAL	EMCYT	EQ 140MG PHOSPHATE	N	18045	1/1/1982	PHARMACIA AND UPJOHN CO
EDROPHONIUM CHLORIDE	INJECTABLE;INJECTION	ENLON	10MG/ML	A	88873	8/6/1985	MYLAN INSTITUTIONAL LLC
ATROPINE SULFATE; EDROPHONIUM CHLORIDE	INJECTABLE;INJECTION	ENLON-PLUS	0.14MG/ML;10MG/ML	N	19678	11/6/1991	MYLAN INSTITUTIONAL LLC
EPINEPHRINE HYDROCHLORIDE	SOLUTION;IV (INFUSION), INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS	EPINEPHRINE	EQ 1MG BASE/ML (EQ 1MG BASE/ML)	N	205029	7/29/2014	BELCHER PHARMACEUTICALS LLC
ERGOTAMINE TARTRATE	TABLET;SUBLINGUAL	ERGOMAR	2MG	A	87693	2/24/1983	ROSEDALE THERAPEUTICS
SERTACONAZOLE NITRATE	CREAM;TOPICAL	ERTACZO	2%	N	21385	12/10/2003	VALEANT PHARMACEUTICALS LUXEMBOURG SARL
ERYTHROMYCIN STEARATE	TABLET;ORAL	ERYTHROCIN STEARATE	EQ 250MG BASE	A	60359	1/1/1982	ARBOR PHARMACEUTICALS LLC
ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL	GRANULE;ORAL	ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL	EQ 200MG BASE/5ML; EQ 600MG BASE/5ML	A	62759	5/20/1988	BARR LABORATORIES INC
ESTRADIOL	CREAM;VAGINAL	ESTRACE	0.01%	A	86069	1/31/1984	WARNER CHILCOTT US LLC
ESTRADIOL; NORGESTIMATE	TABLET;ORAL	ESTRADIOL AND NORGESTIMATE	1MG,1MG;N/A,0.09MG	A	76812	4/29/2005	BARR LABORATORIES INC
ESTRADIOL HEMIHYDRATE	EMULSION;TOPICAL	ESTRASORB	0.25%	N	21371	10/9/2003	MEDICIS PHARMACEUTICAL CORP
ESTRADIOL	INSERT, EXTENDED RELEASE;VAGINAL	ESTRING	0.0075MG/24HR	N	20472	4/26/1996	PHARMACIA AND UPJOHN CO
ETHANOLAMINE OLEATE	INJECTABLE;INJECTION	ETHAMOLIN	50MG/ML	N	19357	12/22/1988	QOL MEDICAL LLC
ETOPOSIDE PHOSPHATE	INJECTABLE;INJECTION	ETOPOPHOS PRESERVATIVE FREE	EQ 100MG BASE/VIAL	N	20457	5/17/1996	BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE
ETOPOSIDE	CAPSULE;ORAL	ETOPOSIDE	50MG	A	75635	9/19/2001	MYLAN PHARMACEUTICALS INC
CROTAMITON	CREAM;TOPICAL	EURAX	10%	N	6927	1/1/1982	RANBAXY LABORATORIES INC
SULCONAZOLE NITRATE	CREAM;TOPICAL	EXELDERM	1%	N	18737	2/28/1989	RANBAXY LABORATORIES INC
SULCONAZOLE NITRATE	SOLUTION;TOPICAL	EXELDERM	1%	N	18738	8/30/1985	RANBAXY LABORATORIES INC
BARIUM SULFATE	FOR SUSPENSION;ORAL	E-Z-HD	334GM/BOTTLE	N	208036	1/11/2016	BRACCO DIAGNOSTICS INC
FAMOTIDINE	SUSPENSION;ORAL	FAMOTIDINE	40MG/5ML	A	201695	12/17/2012	NOVEL LABORATORIES INC
TOREMIFENE CITRATE	TABLET;ORAL	FARESTON	EQ 60MG BASE	N	20497	5/29/1997	PROSTRAKAN INC
FENOPROFEN CALCIUM	TABLET;ORAL	FENOPROFEN CALCIUM	EQ 600MG BASE	A	72267	8/17/1988	MYLAN PHARMACEUTICALS INC
FLUOROMETHOLONE ACETATE	SUSPENSION/DROPS;OPHTHALMIC	FLAREX	0.10%	N	19079	2/11/1986	ALCON LABORATORIES INC
FLUOXYMESTERONE	TABLET;ORAL	FLUOXYMESTERONE	10MG	A	88342	10/21/1983	USL PHARMA INC
FLUPHENAZINE HYDROCHLORIDE	CONCENTRATE;ORAL	FLUPHENAZINE HYDROCHLORIDE	5MG/ML	A	74725	9/16/1996	PHARMACEUTICAL ASSOC INC DIV BEACH PRODUCTS
FLUPHENAZINE HYDROCHLORIDE	ELIXIR;ORAL	FLUPHENAZINE HYDROCHLORIDE	2.5MG/5ML	A	40146	8/21/1996	PHARMACEUTICAL ASSOC INC DIV BEACH PRODUCTS
FLUPHENAZINE HYDROCHLORIDE	INJECTABLE;INJECTION	FLUPHENAZINE HYDROCHLORIDE	2.5MG/ML	A	89556	4/16/1987	FRESENIUS KABI USA LLC
FLUOROMETHOLONE	OINTMENT;OPHTHALMIC	FML	0.10%	N	17760	9/4/1985	ALLERGAN PHARMACEUTICAL
FOLIC ACID	INJECTABLE;INJECTION	FOLIC ACID	5MG/ML	A	89202	2/18/1986	FRESENIUS KABI USA LLC
ENFUVIRTIDE	INJECTABLE;SUBCUTANEOUS	FUZEON	90MG/VIAL	N	21481	3/13/2003	HOFFMANN LA ROCHE INC
CARMUSTINE	IMPLANT;INTRACRANIAL	GLIADEL	7.7MG	N	20637	9/23/1996	ARBOR PHARMACEUTICALS LLC
IOTHALAMATE SODIUM I-125	INJECTABLE;INJECTION	GLOFIL-125	250-300uCi/ML	N	17279	1/1/1982	ISOTEX DIAGNOSTICS
GLUCAGON HYDROCHLORIDE RECOMBINANT	INJECTABLE;INJECTION	GLUCAGEN	EQ 1MG BASE/VIAL	N	20918	6/22/1998	NOVO NORDISK PHARMACEUTICALS INC
GLUCAGON RECOMBINANT	INJECTABLE;INJECTION	GLUCAGON	1MG/VIAL	N	20928	9/11/1998	ELI LILLY AND CO
GLUCAGON HYDROCHLORIDE	POWDER;INTRAMUSCULAR, INTRAVENOUS	GLUCAGON	EQ 1MG BASE/VIAL	N	201849	5/8/2015	FRESENIUS KABI USA LLC
GUANIDINE HYDROCHLORIDE	TABLET;ORAL	GUANIDINE HYDROCHLORIDE	125MG	N	1546	1/1/1982	MERCK SHARP AND DOHME CORP
HALCINONIDE	CREAM;TOPICAL	HALOG	0.10%	N	17556	1/1/1982	RANBAXY LABORATORIES INC
HALCINONIDE	OINTMENT;TOPICAL	HALOG	0.10%	N	17824	1/1/1982	RANBAXY LABORATORIES INC
CARBOPROST TROMETHAMINE	INJECTABLE;INJECTION	HEMABATE	EQ 0.25MG BASE/ML	N	17989	1/1/1982	PHARMACIA AND UPJOHN CO
TECHNETIUM TC-99M DISOFENIN KIT	INJECTABLE;INJECTION	HEPATOLITE	N/A	N	18467	3/16/1982	PHARMALUCENCE INC
ALTRETAMINE	CAPSULE;ORAL	HEXALEN	50MG	N	19926	12/26/1990	EISAI INC
GUAIFENESIN; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE	SOLUTION;ORAL	HYCOFENIX	200MG/5ML;2.5MG/5ML;30MG/5ML	N	22279	5/14/2015	MIKART INC
HYDROCORTISONE VALERATE	OINTMENT;TOPICAL	HYDROCORTISONE VALERATE	0.20%	A	75043	8/25/1998	TARO PHARMACEUTICALS INC
HYDROXYPROGESTERONE CAPROATE	INJECTABLE;INJECTION	HYDROXYPROGESTERONE CAPROATE	250MG/ML	A	200271	8/24/2015	ASPEN GLOBAL INC
CITRIC ACID; UREA C-13	FOR SOLUTION, TABLET, FOR SOLUTION;ORAL	IDKIT:HP	N/A,4GM;75MG,N/A	N	21314	12/17/2002	EXALENZ BIOSCIENCE LTD
INDIUM IN-111 OXYQUINOLINE	INJECTABLE;INJECTION	INDIUM IN-111 OXYQUINOLINE	1mCi/ML	N	19044	12/24/1985	GE HEALTHCARE
INDOMETHACIN	SUSPENSION;ORAL	INDOCIN	25MG/5ML	N	18332	10/10/1985	IROKO PHARMACEUTICALS LLC
INDOMETHACIN	INJECTABLE;INJECTION	INDOMETHACIN	EQ 1MG BASE/VIAL	N	22536	3/17/2010	FRESENIUS KABI USA LLC
INDOMETHACIN	SUPPOSITORY;RECTAL	INDOMETHACIN	50MG	A	73314	8/31/1992	G AND W LABORATORIES INC
CALFACTANT	SUSPENSION;INTRATRACHEAL	INFASURF PRESERVATIVE FREE	35MG/ML	N	20521	7/1/1998	ONY INC
ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5\'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K	INJECTABLE;INJECTION	INFUVITE ADULT	2 IU/ML;40MG/ML; 12MCG/ML;40 IU/ML;1MCG/ML; 3MG/ML;120MCG/ML; 8MG/ML;1.2MG/ML; 0.72MG/ML;1.2MG/ML; 660 IU/ML;0.03MG/ML	N	21163	5/18/2000	SANDOZ CANADA INC
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE; SODIUM LACTATE; SODIUM PHOSPHATE, MONOBASIC ANHYDROUS	INJECTABLE;INJECTION	IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER	5GM/100ML; 53MG/100ML; 100MG/100ML; 100MG/100ML; 180MG/100ML; 280MG/100ML; 16MG/100ML	N	19515	5/8/1986	HOSPIRA INC
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM LACTATE; SODIUM PHOSPHATE, MONOBASIC ANHYDROUS	INJECTABLE;INJECTION	IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER	5GM/100ML; 30MG/100ML; 141MG/100ML; 15MG/100ML; 260MG/100ML; 25MG/100ML	N	19513	5/8/1986	HOSPIRA INC
DESIRUDIN RECOMBINANT	INJECTABLE;SUBCUTANEOUS	IPRIVASK	15MG/VIAL	N	21271	4/4/2003	VALEANT PHARMACEUTICALS NORTH AMERICA LLC
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE	INJECTABLE;INJECTION	ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER	5GM/100ML; 30MG/100ML; 97MG/100ML; 220MG/100ML; 140MG/100ML	N	19844	6/10/1993	B BRAUN MEDICAL INC
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE	INJECTABLE;INJECTION	ISOLYTE M IN DEXTROSE 5% IN PLASTIC CONTAINER	5GM/100ML; 150MG/100ML; 130MG/100ML; 280MG/100ML; 91MG/100ML	N	19870	6/10/1993	B BRAUN MEDICAL INC
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE	INJECTABLE;INJECTION	ISOLYTE P IN DEXTROSE 5% IN PLASTIC CONTAINER	5GM/100ML; 31MG/100ML; 130MG/100ML; 26MG/100ML; 320MG/100ML	N	19873	6/10/1993	B BRAUN MEDICAL INC
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	INJECTABLE;INJECTION	ISOLYTE S PH 7.4 IN PLASTIC CONTAINER	30MG/100ML;37MG/100ML; 0.82MG/100ML; 370MG/100ML; 530MG/100ML; 500MG/100ML;12MG/100ML	N	19696	9/29/1989	B BRAUN MEDICAL INC
ISONIAZID	INJECTABLE;INJECTION	ISONIAZID	100MG/ML	A	40648	7/5/2005	SANDOZ CANADA INC
ISONIAZID	SYRUP;ORAL	ISONIAZID	50MG/5ML	A	88235	11/10/1983	CAROLINA MEDICAL PRODUCTS CO
ISOPROTERENOL HYDROCHLORIDE	INJECTABLE;INJECTION	ISUPREL	0.2MG/ML	N	10515	1/1/1982	HOSPIRA INC
HYDROXYPROPYL CELLULOSE	INSERT;OPHTHALMIC	LACRISERT	5MG	N	18771	1/1/1982	ATON PHARMA INC
LEVORPHANOL TARTRATE	TABLET;ORAL	LEVORPHANOL TARTRATE	2MG	A	74278	3/31/2000	SENTYNL THERAPEUTICS INC
LIDOCAINE HYDROCHLORIDE	INJECTABLE;SPINAL	LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5%	5%	A	83914	1/1/1982	HOSPIRA INC
ACETOHYDROXAMIC ACID	TABLET;ORAL	LITHOSTAT	250MG	N	18749	5/31/1983	MISSION PHARMACAL CO
LOTEPREDNOL ETABONATE	OINTMENT;OPHTHALMIC	LOTEMAX	0.50%	N	200738	4/15/2011	BAUSCH AND LOMB INC
MITOTANE	TABLET;ORAL	LYSODREN	500MG	N	16885	1/1/1982	BRISTOL MYERS SQUIBB
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5\'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E	FOR SOLUTION;IV (INFUSION)	M.V.I. PEDIATRIC	80MG/VIAL;0.02MG/VIAL; 0.001MG/VIAL; 5MG/VIAL;0.01MG/VIAL 0.14MG/VIAL;17MG/VIAL; 0.2MG/VIAL;1MG/VIAL; 1.4MG/VIAL; EQ 1.2MG BASE/VIAL; 0.7MG/VIAL;7MG/VIAL	N	18920	9/21/2000	HOSPIRA INC
MANGANESE CHLORIDE	INJECTABLE;INJECTION	MANGANESE CHLORIDE IN PLASTIC CONTAINER	EQ 0.1MG MANGANESE/ML	N	18962	6/26/1986	HOSPIRA INC
ISOCARBOXAZID	TABLET;ORAL	MARPLAN	10MG	N	11961	1/1/1982	VALIDUS PHARMACEUTICALS INC
PROCARBAZINE HYDROCHLORIDE	CAPSULE;ORAL	MATULANE	EQ 50MG BASE	N	16785	1/1/1982	SIGMA TAU PHARMACEUTICALS INC
DEXAMETHASONE	SUSPENSION/DROPS;OPHTHALMIC	MAXIDEX	0.10%	N	13422	1/1/1982	ALCON LABORATORIES INC
MEBENDAZOLE	TABLET, CHEWABLE;ORAL	MEBENDAZOLE	100MG	A	73580	1/4/1995	AMEDRA PHARMACEUTICALS LLC
MECAMYLAMINE HYDROCHLORIDE	TABLET;ORAL	MECAMYLAMINE HYDROCHLORIDE	2.5MG	A	204054	3/19/2013	NEXGEN PHARMA INC
MEPERIDINE HYDROCHLORIDE	SYRUP;ORAL	MEPERIDINE HYDROCHLORIDE	50MG/5ML	A	88744	1/30/1985	ROXANE LABORATORIES INC
MESNA	TABLET;ORAL	MESNEX	400MG	N	20855	3/21/2002	BAXTER HEALTHCARE CORP
PYRIDOSTIGMINE BROMIDE	SYRUP;ORAL	MESTINON	60MG/5ML	N	15193	1/1/1982	VALEANT PHARMACEUTICALS NORTH AMERICA LLC
METAPROTERENOL SULFATE	SYRUP;ORAL	METAPROTERENOL SULFATE	10MG/5ML	A	73632	7/22/1992	SILARX PHARMACEUTICALS INC
METARAMINOL BITARTRATE	INJECTABLE;INJECTION	METARAMINOL BITARTRATE	EQ 10MG BASE/ML	A	80722	1/1/1982	FRESENIUS KABI USA LLC
ASPIRIN; METHOCARBAMOL	TABLET;ORAL	METHOCARBAMOL AND ASPIRIN	325MG;400MG	A	81145	1/31/1995	JEROME STEVENS PHARMACEUTICALS INC
METHYCLOTHIAZIDE	TABLET;ORAL	METHYCLOTHIAZIDE	5MG	A	87672	8/17/1982	MYLAN PHARMACEUTICALS INC
METHYLDOPATE HYDROCHLORIDE	INJECTABLE;INJECTION	METHYLDOPATE HYDROCHLORIDE	50MG/ML	A	71279	10/2/1987	LUITPOLD PHARMACEUTICALS INC
METHYLERGONOVINE MALEATE	TABLET;ORAL	METHYLERGONOVINE MALEATE	0.2MG	A	91577	5/2/2011	NOVEL LABORATORIES INC
CAFFEINE; ERGOTAMINE TARTRATE	SUPPOSITORY;RECTAL	MIGERGOT	100MG;2MG	A	86557	10/4/1983	HORIZON PHARMA RHEUMATOLOGY LLC
DIHYDROERGOTAMINE MESYLATE	SPRAY, METERED;NASAL	MIGRANAL	0.5MG/INH	N	20148	12/8/1997	VALEANT PHARMACEUTICALS INTERNATIONAL
ACETYLCHOLINE CHLORIDE	FOR SOLUTION;OPHTHALMIC	MIOCHOL-E	20MG/VIAL	N	20213	9/22/1993	BAUSCH AND LOMB INC
CARBACHOL	SOLUTION;INTRAOCULAR	MIOSTAT	0.01%	N	16968	1/1/1982	ALCON LABORATORIES INC
FOSFOMYCIN TROMETHAMINE	FOR SUSPENSION;ORAL	MONUROL	EQ 3GM BASE/PACKET	N	50717	12/19/1996	ZAMBON SPA ITALY
TECHNETIUM TC-99M SUCCIMER KIT	INJECTABLE;INJECTION	MPI DMSA KIDNEY REAGENT	N/A	N	17944	5/18/1982	GE HEALTHCARE
INDIUM IN-111 PENTETATE DISODIUM	INJECTABLE;INTRATHECAL	MPI INDIUM DTPA IN 111	1mCi/ML	N	17707	2/18/1982	GE HEALTHCARE
MECHLORETHAMINE HYDROCHLORIDE	INJECTABLE;INJECTION	MUSTARGEN	10MG/VIAL	N	6695	1/1/1982	RECORDATI RARE DISEASES INC
BUSULFAN	TABLET;ORAL	MYLERAN	2MG	N	9386	1/1/1982	ASPEN GLOBAL INC
NANDROLONE DECANOATE	INJECTABLE;INJECTION	NANDROLONE DECANOATE	200MG/ML	A	91252	8/30/2010	PHARMAFORCE INC
NAPHAZOLINE HYDROCHLORIDE	SOLUTION/DROPS;OPHTHALMIC	NAPHAZOLINE HYDROCHLORIDE	0.10%	A	83590	1/1/1982	AKORN INC
NATAMYCIN	SUSPENSION;OPHTHALMIC	NATACYN	5%	N	50514	1/1/1982	ALCON LABORATORIES INC
NESIRITIDE RECOMBINANT	FOR SOLUTION;INTRAVENOUS	NATRECOR	1.5MG/VIAL	N	20920	8/10/2001	SCIOS LLC
PENTAMIDINE ISETHIONATE	FOR SOLUTION;INHALATION	NEBUPENT	300MG/VIAL	N	19887	6/15/1989	FRESENIUS KABI USA LLC
PENTOBARBITAL SODIUM	INJECTABLE;INJECTION	NEMBUTAL SODIUM	50MG/ML	A	83246	1/1/1982	OAK PHARMACEUTICALS INC
NEOMYCIN SULFATE	SOLUTION;ORAL	NEO-FRADIN	EQ 87.5MG BASE/5ML	A	65010	5/23/2002	X GEN PHARMACEUTICALS INC
HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	SUSPENSION/DROPS;OPHTHALMIC	NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE	1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML	A	62874	5/11/1988	ALCON PHARMACEUTICALS LTD
FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE	CREAM;TOPICAL	NEO-SYNALAR	0.025%;EQ 3.5MG BASE/GM	A	60700	1/1/1982	MEDIMETRIKS PHARMACEUTICALS INC
TECHNETIUM TC-99M BICISATE KIT	INJECTABLE;INJECTION	NEUROLITE	N/A	N	20256	11/23/1994	LANTHEUS MEDICAL IMAGING INC
NICOTINE	INHALANT;ORAL	NICOTROL	4MG/CARTRIDGE	N	20714	5/2/1997	PHARMACIA AND UPJOHN CO
NICOTINE	SPRAY, METERED;NASAL	NICOTROL	0.5MG/SPRAY	N	20385	3/22/1996	PFIZER INC
NITROGLYCERIN	OINTMENT;TRANSDERMAL	NITROGLYCERIN	2%	A	87355	7/8/1988	E FOUGERA DIV ALTANA INC
SODIUM NITROPRUSSIDE	INJECTABLE;INJECTION	NITROPRESS	25MG/ML	A	71961	8/1/1988	HOSPIRA WORLDWIDE, INC
NIZATIDINE	SOLUTION;ORAL	NIZATIDINE	15MG/ML	A	90576	11/18/2009	AMNEAL PHARMACEUTICALS
ETHINYL ESTRADIOL; NORGESTIMATE	TABLET;ORAL	NORGESTIMATE AND ETHINYL ESTRADIOL	0.035MG,0.035MG, 0.035MG;0.18MG, 0.215MG,0.25MG	A	200494	6/17/2011	GLENMARK GENERICS LTD
MESTRANOL; NORETHINDRONE	TABLET;ORAL-28	NORINYL 1+50 28-DAY	0.05MG;1MG	N	16659	1/1/1982	ACTAVIS LABORATORIES UT INC
DEXTROSE; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE	INJECTABLE;INJECTION	NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER	5GM/100ML; 21MG/100ML; 128MG/100ML; 234MG/100ML	N	17610	1/1/1982	HOSPIRA INC
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE	INJECTABLE;INJECTION	NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER	5GM/100ML; 30MG/100ML; 37MG/100ML; 222MG/100ML; 526MG/100ML; 502MG/100ML	N	17609	1/1/1982	HOSPIRA INC
GLUTAMINE	FOR SOLUTION;ORAL	NUTRESTORE	5GM/PACKET	N	21667	6/10/2004	EMMAUS MEDICAL INC
NYSTATIN	TABLET;VAGINAL	NYSTATIN	100,000 UNITS	A	62615	10/17/1985	ODYSSEY PHARMACEUTICALS INC
AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE	CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL	OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN	500MG,N/A,N/A; N/A,500MG,N/A; N/A,N/A,20MG	N	50824	2/8/2011	GASTROENTERO LOGIC LLC
IOHEXOL	FOR SOLUTION;ORAL	ORALTAG	9.7GM/BOT	N	205383	3/26/2015	INTERPHARMA PRAHA AS
OXICONAZOLE NITRATE	LOTION;TOPICAL	OXISTAT	EQ 1% BASE	N	20209	9/30/1992	FOUGERA PHARMACEUTICALS INC
HYDROCORTISONE PROBUTATE	CREAM;TOPICAL	PANDEL	0.10%	N	20453	2/28/1997	FOUGERA PHARMACEUTICALS INC
COPPER	INTRAUTERINE DEVICE;INTRAUTERINE	PARAGARD T 380A	309MG/COPPER	N	18680	11/15/1984	TEVA WOMENS HEALTH INC
HYDROXYAMPHETAMINE HYDROBROMIDE; TROPICAMIDE	SOLUTION/DROPS;OPHTHALMIC	PAREMYD	1%;0.25%	N	19261	1/30/1992	AKORN INC
AMINOSALICYLIC ACID	GRANULE, DELAYED RELEASE;ORAL	PASER	4GM/PACKET	A	74346	6/30/1994	JACOBUS PHARMACEUTICAL CO
BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE	FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL	PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL	5MG,N/A;N/A,210GM; N/A,0.74GM; N/A,2.86GM; N/A,5.6GM	A	202217	8/20/2014	NOVEL LABORATORIES INC
ETHOTOIN	TABLET;ORAL	PEGANONE	250MG	N	10841	1/1/1982	RECORDATI RARE DISEASES INC
PENICILLIN G SODIUM	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	PENICILLIN G SODIUM	5,000,000 UNITS/VIAL	A	65068	2/26/2001	SANDOZ INC
PENTAMIDINE ISETHIONATE	INJECTABLE;INJECTION	PENTAM	300MG/VIAL	N	19264	10/16/1984	FRESENIUS KABI USA LLC
CHLORHEXIDINE GLUCONATE	TABLET;DENTAL	PERIOCHIP	2.5MG	N	20774	5/15/1998	DEXCEL PHARMA TECHNOLOGIES LTD
PHENDIMETRAZINE TARTRATE	CAPSULE, EXTENDED RELEASE;ORAL	PHENDIMETRAZINE TARTRATE	105MG	N	18074	1/1/1982	SANDOZ INC
HEXACHLOROPHENE	EMULSION;TOPICAL	PHISOHEX	3%	N	6882	1/1/1982	SANOFI AVENTIS US LLC
ECHOTHIOPHATE IODIDE	FOR SOLUTION;OPHTHALMIC	PHOSPHOLINE IODIDE	0.13%	N	11963	1/1/1982	WYETH PHARMACEUTICALS INC
PORFIMER SODIUM	INJECTABLE;INJECTION	PHOTOFRIN	75MG/VIAL	N	20451	12/27/1995	CONCORDIA LABORATORIES INC
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	INJECTABLE;IV (INFUSION)	PIPERACILLIN AND TAZOBACTAM	EQ 12GM BASE/VIAL;EQ 1.5GM BASE/VIAL	A	203557	10/29/2014	SANDOZ INC
DEXTROSE; MAGNESIUM ACETATE TETRAHYDRATE; POTASSIUM ACETATE; SODIUM CHLORIDE	INJECTABLE;INJECTION	PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER	5GM/100ML; 32MG/100ML; 128MG/100ML; 234MG/100ML	N	17385	1/1/1982	BAXTER HEALTHCARE CORP
POTASSIUM CHLORIDE	FOR SOLUTION;ORAL	POTASSIUM CHLORIDE	20MEQ	N	208019	8/19/2015	PHARMA RESEARCH SOFTWARE SOLUTION LLC
GENTAMICIN SULFATE; PREDNISOLONE ACETATE	OINTMENT;OPHTHALMIC	PRED-G	EQ 0.3% BASE;0.6%	N	50612	12/1/1989	ALLERGAN PHARMACEUTICAL
GENTAMICIN SULFATE; PREDNISOLONE ACETATE	SUSPENSION/DROPS;OPHTHALMIC	PRED-G	EQ 0.3% BASE;1%	N	50586	6/10/1988	ALLERGAN PHARMACEUTICAL
PREDNISOLONE	TABLET;ORAL	PREDNISOLONE	5MG	A	80354	1/1/1982	WATSON LABORATORIES INC
PREDNISOLONE SODIUM PHOSPHATE	SOLUTION/DROPS;OPHTHALMIC	PREDNISOLONE SODIUM PHOSPHATE	EQ 0.9% PHOSPHATE	A	40070	7/29/1994	BAUSCH AND LOMB PHARMACEUTICALS INC
ESTROGENS, CONJUGATED	CREAM;TOPICAL, VAGINAL	PREMARIN	0.625MG/GM	N	20216	1/1/1982	WYETH PHARMACEUTICALS INC
ESTROGENS, CONJUGATED	INJECTABLE;INJECTION	PREMARIN	25MG/VIAL	N	10402	1/1/1982	WYETH PHARMACEUTICALS INC
BENZYLPENICILLOYL POLYLYSINE	INJECTABLE;INJECTION	PRE-PEN	60UMOLAR	N	50114	1/1/1982	ALLERQUEST LLC
DINOPROSTONE	GEL;ENDOCERVICAL	PREPIDIL	0.5MG/3GM	N	19617	12/9/1992	PHARMACIA AND UPJOHN CO
RIFAPENTINE	TABLET;ORAL	PRIFTIN	150MG	N	21024	6/22/1998	SANOFI AVENTIS US LLC
PRILOCAINE HYDROCHLORIDE	INJECTABLE;INJECTION	PRILOCAINE HYDROCHLORIDE	4%	A	79235	9/29/2010	SEPTODONT INC
CILASTATIN SODIUM; IMIPENEM	POWDER;INTRAMUSCULAR	PRIMAXIN	EQ 500MG BASE/VIAL;500MG/VIAL	N	50630	12/14/1990	MERCK AND CO INC
AMINO ACIDS; CALCIUM ACETATE; GLYCERIN; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE	INJECTABLE;INJECTION	PROCALAMINE	3%;26MG/100ML;3GM/100ML; 54MG/100ML;41MG/100ML; 150MG/100ML;200MG/100ML; 120MG/100ML	N	18582	5/8/1982	B BRAUN MEDICAL INC
DIAZOXIDE	SUSPENSION;ORAL	PROGLYCEM	50MG/ML	N	17453	1/1/1982	TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC
TACROLIMUS	INJECTABLE;INJECTION	PROGRAF	EQ 5MG BASE/ML	N	50709	4/8/1994	ASTELLAS PHARMA US INC
DINOPROSTONE	SUPPOSITORY;VAGINAL	PROSTIN E2	20MG	N	17810	1/1/1982	PHARMACIA AND UPJOHN CO
PROTAMINE SULFATE	INJECTABLE;INJECTION	PROTAMINE SULFATE	10MG/ML	A	89454	4/7/1987	FRESENIUS KABI USA LLC
METHACHOLINE CHLORIDE	FOR SOLUTION;INHALATION	PROVOCHOLINE	100MG/VIAL	N	19193	10/31/1986	METHAPHARM INC
PYRIDOXINE HYDROCHLORIDE	INJECTABLE;INJECTION	PYRIDOXINE HYDROCHLORIDE	100MG/ML	A	80618	1/1/1982	FRESENIUS KABI USA LLC
SAMARIUM SM-153 LEXIDRONAM PENTASODIUM	INJECTABLE;INJECTION	QUADRAMET	50mCi/ML	N	20570	3/28/1997	LANTHEUS MEDICAL IMAGING INC
QUINIDINE GLUCONATE	TABLET, EXTENDED RELEASE;ORAL	QUINIDINE GLUCONATE	324MG	A	89338	2/11/1987	MUTUAL PHARMACEUTICAL CO INC
QUINIDINE SULFATE	TABLET, EXTENDED RELEASE;ORAL	QUINIDINE SULFATE	300MG	A	40045	6/30/1994	G AND W LABORATORIES INC
FERRIC HEXACYANOFERRATE(II)	CAPSULE;ORAL	RADIOGARDASE (PRUSSIAN BLUE)	500MG	N	21626	10/2/2003	HEYL CHEMISCH PHARMAZEUTISHE FABRIK
NITROGLYCERIN	OINTMENT;INTRA-ANAL	RECTIV	0.40%	N	21359	6/21/2011	FOREST LABORATORIES INC
ZANAMIVIR	POWDER;INHALATION	RELENZA	5MG	N	21036	7/26/1999	GLAXOSMITHKLINE
CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE	SOLUTION;IRRIGATION	RENACIDIN	6.602GM/100ML; 198MG/100ML; 3.177GM/100ML	N	19481	10/2/1990	UNITED GUARDIAN INC
TRETINOIN	SOLUTION;TOPICAL	RETIN-A	0.05%	N	16921	1/1/1982	VALEANT INTERNATIONAL BARBADOS SRL
ARGININE HYDROCHLORIDE	INJECTABLE;INJECTION	R-GENE 10	10GM/100ML	N	16931	1/1/1982	PHARMACIA AND UPJOHN CO
AURANOFIN	CAPSULE;ORAL	RIDAURA	3MG	N	18689	5/24/1985	SEBELA IRELAND LTD
ISONIAZID; RIFAMPIN	CAPSULE;ORAL	RIFAMATE	150MG;300MG	A	61884	1/1/1982	SANOFI AVENTIS US LLC
ISONIAZID; PYRAZINAMIDE; RIFAMPIN	TABLET;ORAL	RIFATER	50MG;300MG;120MG	N	50705	5/31/1994	SANOFI AVENTIS US LLC
HYDROFLUMETHIAZIDE	TABLET;ORAL	SALURON	50MG	N	11949	1/1/1982	SHIRE DEVELOPMENT LLC
LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE	INJECTABLE;INJECTION	SCANDONEST L	0.05MG/ML;2%	A	88388	10/10/1984	DEPROCO INC
TALC	AEROSOL, METERED;INTRAPLEURAL	SCLEROSOL	400MG/SPRAY	N	20587	12/24/1997	BRYAN CORP
ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE	CAPSULE;ORAL	SEMPREX-D	8MG;60MG	N	19806	3/25/1994	AUXILIUM PHARMACEUTICALS LLC
BETAMETHASONE DIPROPIONATE	SPRAY;TOPICAL	SERNIVO	EQ 0.05% BASE/SPRAY	N	208079	2/5/2016	PROMIUS PHARMA LLC
CYCLOSERINE	CAPSULE;ORAL	SEROMYCIN	250MG	A	60593	1/1/1982	PURDUE GMP CENTER LLC DBA THE CHAO CENTER INDUSTRIAL PHARMACY
SODIUM ACETATE ANHYDROUS	INJECTABLE;INJECTION	SODIUM ACETATE IN PLASTIC CONTAINER	2MEQ/ML	N	18893	5/4/1983	HOSPIRA INC
SODIUM LACTATE	INJECTABLE;INJECTION	SODIUM LACTATE IN PLASTIC CONTAINER	5MEQ/ML	N	18947	9/5/1984	HOSPIRA INC
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	INJECTABLE;INJECTION	SODIUM PHOSPHATES IN PLASTIC CONTAINER	142MG/ML;276MG/ML	N	18892	5/10/1983	HOSPIRA INC
MANNITOL; SORBITOL	SOLUTION;IRRIGATION	SORBITOL-MANNITOL IN PLASTIC CONTAINER	540MG/100ML;2.7GM/100ML	N	18316	1/1/1982	HOSPIRA INC
SOTALOL HYDROCHLORIDE	SOLUTION;ORAL	SOTYLIZE	5MG/ML (5MG/ML)	N	205108	10/22/2014	ARBOR PHARMACEUTICALS LLC
STREPTOMYCIN SULFATE	INJECTABLE;INJECTION	STREPTOMYCIN SULFATE	EQ 1GM BASE/VIAL	A	64210	6/30/1998	X GEN PHARMACEUTICALS INC
SACROSIDASE	SOLUTION;ORAL	SUCRAID	8,500 IU/ML	N	20772	4/9/1998	QOL MEDICAL LLC
SULFACETAMIDE SODIUM	OINTMENT;OPHTHALMIC	SULFACETAMIDE SODIUM	10%	A	80029	1/1/1982	PERRIGO CO TENNESSEE INC
SULFADIAZINE	TABLET;ORAL	SULFADIAZINE	500MG	A	40091	7/29/1994	SANDOZ INC
SULFAMETHOXAZOLE; TRIMETHOPRIM	INJECTABLE;INJECTION	SULFAMETHOXAZOLE AND TRIMETHOPRIM	80MG/ML;16MG/ML	A	73303	10/31/1991	TEVA PHARMACEUTICALS USA
MAFENIDE ACETATE	CREAM;TOPICAL	SULFAMYLON	EQ 85MG BASE/GM	N	16763	1/1/1982	MYLAN INSTITUTIONAL INC
DESFLURANE	LIQUID;INHALATION	SUPRANE	99.90%	N	20118	9/18/1992	BAXTER HEALTHCARE CORP
CEFIXIME	CAPSULE;ORAL	SUPRAX	400MG	N	203195	6/1/2012	LUPIN LTD
CEFIXIME	TABLET;ORAL	SUPRAX	400MG	A	65130	2/12/2004	LUPIN PHARMACEUTICALS INC
BERACTANT	SUSPENSION;INTRATRACHEAL	SURVANTA	25MG/ML	N	20032	7/1/1991	ABBVIE INC
NAFARELIN ACETATE	SPRAY, METERED;NASAL	SYNAREL	EQ 0.2MG BASE/SPRAY	N	19886	2/13/1990	GD SEARLE LLC
DALFOPRISTIN; QUINUPRISTIN	INJECTABLE;IV (INFUSION)	SYNERCID	350MG/VIAL;150MG/VIAL	N	50748	9/21/1999	KING PHARMACEUTICALS INC
TRIENTINE HYDROCHLORIDE	CAPSULE;ORAL	SYPRINE	250MG	N	19194	11/8/1985	ATON PHARMA INC
TALC	POWDER;INTRAPLEURAL	TALC	5GM/BOT	N	21388	12/15/2003	BRYAN CORP
PENTAZOCINE LACTATE	INJECTABLE;INJECTION	TALWIN	EQ 30MG BASE/ML	N	16194	1/1/1982	HOSPIRA INC
TECHNETIUM TC-99M OXIDRONATE KIT	INJECTABLE;INJECTION	TECHNESCAN	N/A	N	18321	1/1/1982	MALLINCKRODT NUCLEAR MEDICINE LLC
TECHNETIUM TC-99M MERTIATIDE KIT	INJECTABLE;INJECTION	TECHNESCAN MAG3	N/A	N	19882	6/15/1990	MALLINCKRODT NUCLEAR MEDICINE LLC
OXYTETRACYCLINE HYDROCHLORIDE; POLYMYXIN B SULFATE	OINTMENT;OPHTHALMIC	TERRAMYCIN W/ POLYMYXIN B SULFATE	EQ 5MG BASE/GM;10,000 UNITS/GM	A	61015	1/1/1982	PFIZER LABORATORIES DIV PFIZER INC
TESTOSTERONE	PELLET;IMPLANTATION	TESTOPEL	75MG	A	80911	1/1/1982	ACTIENT PHARMACEUTICALS LLC
TETRACAINE HYDROCHLORIDE	SOLUTION;OPHTHALMIC	TETRACAINE HYDROCHLORIDE	0.50%	N	208135	2/29/2016	ALCON RESEARCH LTD
HYDROCORTISONE	SOLUTION;TOPICAL	TEXACORT	2.50%	A	81271	4/17/1992	MISSION PHARMACAL CO
THIOGUANINE	TABLET;ORAL	THIOGUANINE	40MG	N	12429	1/1/1982	ASPEN GLOBAL INC
TIOPRONIN	TABLET;ORAL	THIOLA	100MG	N	19569	8/11/1988	MISSION PHARMACAL CO
THIOTEPA	INJECTABLE;INJECTION	THIOTEPA	15MG/VIAL	A	75547	4/2/2001	EUROHEALTH INTERNATIONAL SARL
DEXAMETHASONE; TOBRAMYCIN	OINTMENT;OPHTHALMIC	TOBRADEX	0.1%;0.3%	N	50616	9/28/1988	ALCON LABORATORIES INC
TOBRAMYCIN	OINTMENT;OPHTHALMIC	TOBREX	0.30%	N	50555	1/1/1982	ALCON LABORATORIES INC
TOLBUTAMIDE	TABLET;ORAL	TOLBUTAMIDE	500MG	A	86445	1/1/1982	MYLAN PHARMACEUTICALS INC
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE	INJECTABLE;INJECTION	TPN ELECTROLYTES IN PLASTIC CONTAINER	16.5MG/ML;25.4MG/ML; 74.6MG/ML;121MG/ML; 16.1MG/ML	N	18895	7/20/1984	HOSPIRA INC
ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE	CAPSULE;ORAL	TREZIX	320.5MG;30MG;16MG	A	204785	11/26/2014	WRASER PHARMACEUTICALS LLC
CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	SYRUP;ORAL	TRIACIN-C	10MG/5ML;30MG/5ML;1.25MG/5ML	A	88704	3/22/1985	STI PHARMA LLC
HYDROCORTISONE ACETATE; UREA	CREAM;TOPICAL	U-CORT	1%;10%	A	89472	6/13/1988	TARO PHARMACEUTICALS USA INC
TECHNETIUM TC-99M RED BLOOD CELL KIT	INJECTABLE;INJECTION	ULTRATAG	N/A	N	19981	6/10/1991	MALLINCKRODT NUCLEAR MEDICINE LLC
METHOXSALEN	INJECTABLE;INJECTION	UVADEX	0.02MG/ML	N	20969	2/25/1999	THERAKOS INC
VALRUBICIN	SOLUTION;INTRAVESICAL	VALSTAR PRESERVATIVE FREE	40MG/ML	N	20892	9/25/1998	ENDO PHARMACEUTICAL SOLUTIONS INC
VANCOMYCIN HYDROCHLORIDE	POWDER;IV (INFUSION)	VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER	EQ 100GM BASE	A	91532	1/6/2016	SAMSON MEDICAL TECHNOLOGIES LLC
EFLORNITHINE HYDROCHLORIDE	CREAM;TOPICAL	VANIQA	13.90%	N	21145	7/27/2000	SKINMEDICA INC
VASOPRESSIN	SOLUTION;IV (INFUSION)	VASOSTRICT	20UNITS/ML (20UNITS/ML)	N	204485	4/17/2014	PAR STERILE PRODUCTS LLC
CALCITRIOL	OINTMENT;TOPICAL	VECTICAL	3MCG/GM	N	22087	1/23/2009	GALDERMA LABORATORIES LP
CLOZAPINE	SUSPENSION;ORAL	VERSACLOZ	50MG/ML	N	203479	2/6/2013	JAZZ PHARMACEUTICALS INTERNATIONAL III
RIMEXOLONE	SUSPENSION/DROPS;OPHTHALMIC	VEXOL	1%	N	20474	12/30/1994	ALCON LABORATORIES INC
DOXYCYCLINE CALCIUM	SUSPENSION;ORAL	VIBRAMYCIN	EQ 50MG BASE/5ML	N	50480	1/1/1982	PFIZER LABORATORIES DIV PFIZER INC
TENIPOSIDE	INJECTABLE;INJECTION	VUMON	10MG/ML	N	20119	7/14/1992	HQ SPECIALTY PHARMA
ETHINYL ESTRADIOL; NORELGESTROMIN	FILM, EXTENDED RELEASE;TRANSDERMAL	XULANE	0.035MG/24HR;0.15MG/24HR	A	200910	4/16/2014	MYLAN TECHNOLOGIES
STREPTOZOCIN	INJECTABLE;INJECTION	ZANOSAR	1GM/VIAL	N	50577	5/7/1982	TEVA PHARMACEUTICALS USA
MIGLUSTAT	CAPSULE;ORAL	ZAVESCA	100MG	N	21348	7/31/2003	ACTELION PHARMACEUTICALS LTD
SUMATRIPTAN SUCCINATE	SOLUTION;SUBCUTANEOUS	ZEMBRACE SYMTOUCH	EQ 3MG BASE/0.5ML (EQ 3MG BASE/0.5ML)	N	208223	1/28/2016	DR REDDYS LABORATORIES LTD
ZINC CHLORIDE	INJECTABLE;INJECTION	ZINC CHLORIDE IN PLASTIC CONTAINER	EQ 1MG ZINC/ML	N	18959	6/26/1986	HOSPIRA INC
ZOLEDRONIC ACID	SOLUTION;IV (INFUSION)	ZOLEDRONIC ACID	EQ 4MG BASE/100ML (EQ 0.04MG BASE/ML)	N	204016	12/28/2015	HOSPIRA INC
DOXEPIN HYDROCHLORIDE	CREAM;TOPICAL	ZONALON	5%	N	20126	4/1/1994	DELCOR ASSET CORP
ACYCLOVIR	CREAM;TOPICAL	ZOVIRAX	5%	N	21478	12/30/2002	VALEANT INTERNATIONAL BERMUDA
ZILEUTON	TABLET, EXTENDED RELEASE;ORAL	ZYFLO CR	600MG	N	22052	5/30/2007	CHIESI USA INC
LOTEPREDNOL ETABONATE; TOBRAMYCIN	SUSPENSION/DROPS;OPHTHALMIC	ZYLET	0.5%;0.3%	N	50804	12/14/2004	BAUSCH AND LOMB INC